drugset
drugset / Trial / NCT03617445

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

NCT03617445 ↗

Phase 2 Terminated 3 enrolled University of Wisconsin, Madison National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective is to examine the effect of Fecal Microbiota Transplantation (FMT) compared with vancomycin for cure of recurrent C. diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial.

Timeline

Start
2022-08-03
Primary completion
2023-06-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator FMT oral capsule Unknown 5 unknown Oral
Comparator Vancomycin Other / unclassified 125 mg Oral

Indications

Clostridium difficile colitis